These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19901108

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
    Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP.
    Cancer Res; 2008 Dec 15; 68(24):10349-57. PubMed ID: 19074904
    [Abstract] [Full Text] [Related]

  • 3. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
    Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C, Kreil S, Jones A, Score J, Metzgeroth G, Oscier D, Hall A, Brandts C, Serve H, Reiter A, Chase AJ, Cross NC.
    Blood; 2009 Jun 11; 113(24):6182-92. PubMed ID: 19387008
    [Abstract] [Full Text] [Related]

  • 4. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.
    Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP.
    Blood; 2010 Mar 11; 115(10):1969-75. PubMed ID: 20008299
    [Abstract] [Full Text] [Related]

  • 5. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
    Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, Oda H, Yamagata T, Takita J, Gotoh N, Nakazaki K, Kawamata N, Onodera M, Nobuyoshi M, Hayashi Y, Harada H, Kurokawa M, Chiba S, Mori H, Ozawa K, Omine M, Hirai H, Nakauchi H, Koeffler HP, Ogawa S.
    Nature; 2009 Aug 13; 460(7257):904-8. PubMed ID: 19620960
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
    Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP.
    Blood; 2009 Jun 18; 113(25):6403-10. PubMed ID: 19372255
    [Abstract] [Full Text] [Related]

  • 7. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
    Kao HW, Sanada M, Liang DC, Lai CL, Lee EH, Kuo MC, Lin TL, Shih YS, Wu JH, Huang CF, Ogawa S, Shih LY.
    Neoplasia; 2011 Nov 18; 13(11):1035-42. PubMed ID: 22131879
    [Abstract] [Full Text] [Related]

  • 8. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
    Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP.
    Blood; 2008 Feb 01; 111(3):1534-42. PubMed ID: 17954704
    [Abstract] [Full Text] [Related]

  • 9. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J.
    Int J Lab Hematol; 2015 Apr 01; 37(2):181-9. PubMed ID: 24845343
    [Abstract] [Full Text] [Related]

  • 10. Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.
    Ogawa S, Sanada M, Shih LY, Suzuki T, Otsu M, Nakauchi H, Koeffler HP.
    Cell Cycle; 2010 Mar 15; 9(6):1051-6. PubMed ID: 20237427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
    Hanson HL, Wilson MJ, Short JP, Chioza BA, Crosby AH, Nash RM, Marks KJ, Mansour S.
    Am J Med Genet A; 2014 Apr 15; 164A(4):1003-9. PubMed ID: 24458550
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger S.
    Leukemia; 2013 Sep 15; 27(9):1852-60. PubMed ID: 23628959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.